Amylase

Nucific Invites You To Nuture Your Gut Microbiome and Celebrate World Health Day with Nucific Bio-X4

Retrieved on: 
Sunday, April 7, 2024
Health, Metabolism, Nutrient, Appetite, World Health Day, Probiotic, EGCG, Weight loss, Sale, Amylase, Lactobacillus, Snack, Digestion, Dietary supplement

LOS ANGELES, April 7, 2024 /PRNewswire/ -- World Health Day, observed annually on April 7th, serves as a global platform to raise awareness about pressing health issues and advocate for universal healthcare access. It aims to mobilize individuals and communities to take proactive steps towards maintaining and improving their health.

Key Points: 
  • Renowned nutritionist and Nucific® founder, Dr. Amy Lee stresses the significance of nurturing your microbiome as the cornerstone of overall health.
  • Additionally, the gut microbiome impacts various health aspects, such as mental well-being, weight management, and healthy skin.
  • Nucific's Dr. Amy Lee recommends taking care of your gut health in honor of World Health Day with supplements like Nucific BIO-X4 .
  • Nucific Bio-X4 is a groundbreaking weight support formula that contains advanced probiotics, which flood your gut with healthy slimming power.

United States Biofuel Enzyme Markets, Competition, Forecast and Opportunities, 2018-2023 and 2028F: Innovations and Environmental Benefits, Automotive Industry Influence and Industrial Scale-Up - ResearchAndMarkets.com

Retrieved on: 
Wednesday, April 3, 2024
Alternative Energy, Energy, Oil, Gas, Momentum, Renewable energy, Fossil, Transport, Amylase, Government, Biofuel, Biomass

The "United States Biofuel Enzyme Market, By Region, Competition Forecast and Opportunities, 2018-2028F" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "United States Biofuel Enzyme Market, By Region, Competition Forecast and Opportunities, 2018-2028F" report has been added to ResearchAndMarkets.com's offering.
  • The United States has witnessed a significant surge in the demand for biofuel enzymes, an integral component in the production of cleaner, renewable energy.
  • A new comprehensive analysis of the United States Biofuel Enzyme Market details evolutionary trends, competitive landscapes, and regional market insights, aimed at providing stakeholders with a thorough understanding of the market dynamics in this crucial sector.
  • The increasing propensity for renewable alternatives in the United States augments the role of biofuel enzymes in meeting energy needs sustainably.

VIVUS Provides Update on Pipeline and Program Milestones

Retrieved on: 
Monday, January 8, 2024
Patient, Quality of life, HIV/AIDS, Bloating, Diarrhea, Inflammatory bowel disease, ABPM, Chronic pain, Enzyme replacement therapy, Cystic fibrosis, Heart, Degenerative disease, Exocrine pancreatic insufficiency, Comorbidity, Steatorrhea, Obesity, HIV, Amylase, Orthostatic hypertension, Phentermine, Heart failure, Exercise, Pharmaceutical industry

CAMPBELL, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- VIVUS LLC, a biopharmaceutical company committed to the development and commercialization of innovative therapies that focus on advancing treatments for patients with serious unmet medical needs, today announced pipeline updates and program milestones.

Key Points: 
  • CAMPBELL, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- VIVUS LLC, a biopharmaceutical company committed to the development and commercialization of innovative therapies that focus on advancing treatments for patients with serious unmet medical needs, today announced pipeline updates and program milestones.
  • “VIVUS has been continuously dedicated to addressing the therapeutic needs of patients with serious medical conditions and life-limiting diseases, including exocrine pancreatic insufficiency, obesity and pulmonary arterial hypertension,” said John Amos, Chief Executive Officer at VIVUS LLC.
  • QSYMIA® is now the number one branded oral product in the US for obesity treatment.
  • Moreover, VIVUS is actively developing pipeline products focusing on bone marrow transplant preparation (VI-0609) and diabetes treatments (VI-0809 and VI-0810).”

Global Biofuel Enzymes Market Trends and Forecast Report 2023-2030: Flex-fuel Vehicles are Driving the Demand for Biofuels

Retrieved on: 
Wednesday, November 15, 2023
Amylase, Growth, Biofuel, Ethanol, Traction, Research, Natural gas, Genetic engineering, Cellulase, Compound annual growth rate, Enzyme, Gasoline, Renewable energy, Pet industry, Jet fuel, Agriculture

DUBLIN, Nov. 15, 2023 /PRNewswire/ -- The "Biofuel Enzymes - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Nov. 15, 2023 /PRNewswire/ -- The "Biofuel Enzymes - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.
  • The global market for Biofuel Enzymes is expected to reach approximately $1.9 billion by 2030, growing from $1 billion in 2022.
  • An expanding role of renewable fuels in the global energy mix is creating opportunities for biofuels.
  • The global shift away from fossil fuels and increasing demand for alternate fuels in the automotive industry are providing growth opportunities.

Biocatalyst Market to Reach $2.1 Billion, Globally, by 2032 at 6.7% CAGR: Allied Market Research

Retrieved on: 
Thursday, July 13, 2023
Pharmacy, Hydrolase, Food, Enzyme, Fats, Table, Biotechnology, Sugar, Research, Chart, Climate change, Amylase, Biofuel, Transferase, API, PDF, Biomass, Cellulase, Fine chemical

PORTLAND, Ore., July 13, 2023 /PRNewswire/ -- Allied Market Research published a report, titled, "Biocatalyst Market by Source (Plant, Animal, Microorganism), By Type (Oxidoreductases, Transferases, Hydrolases, and Others), By End-Use Industry (pharmaceutical, food & beverage, water treatment, biofuel, and others): Global Opportunity Analysis and Industry Forecast, 2023-2032." According to the report, the global biocatalyst industry was valued at $1.1 billion in 2022 and is estimated to reach $2.1 billion by 2032, exhibiting a CAGR of 6.7% from 2023 to 2032.

Key Points: 
  • However, the animal-based biocatalyst segment would display the fastest CAGR of 6.9% from 2023 to 2032, owing to increased demand from the food and beverage industry.
  • On the other hand, the transferases segment would portray the fastest CAGR of 7.0% during the forecast period.
  • Transferases are extensively used in biotechnology and pharmaceutical research for a wide range of applications.
  • The country has a well-established biotechnology industry and is actively investing in research and development of biocatalyst technologies.

Biocatalyst Market to Reach $2.1 Billion, Globally, by 2032 at 6.7% CAGR: Allied Market Research

Retrieved on: 
Thursday, July 13, 2023
Pharmacy, Hydrolase, Food, Enzyme, Fats, Table, Biotechnology, Sugar, Research, Chart, Climate change, Amylase, Biofuel, Transferase, API, PDF, Biomass, Cellulase, Fine chemical

PORTLAND, Ore., July 13, 2023 /PRNewswire/ -- Allied Market Research published a report, titled, "Biocatalyst Market by Source (Plant, Animal, Microorganism), By Type (Oxidoreductases, Transferases, Hydrolases, and Others), By End-Use Industry (pharmaceutical, food & beverage, water treatment, biofuel, and others): Global Opportunity Analysis and Industry Forecast, 2023-2032." According to the report, the global biocatalyst industry was valued at $1.1 billion in 2022 and is estimated to reach $2.1 billion by 2032, exhibiting a CAGR of 6.7% from 2023 to 2032.

Key Points: 
  • However, the animal-based biocatalyst segment would display the fastest CAGR of 6.9% from 2023 to 2032, owing to increased demand from the food and beverage industry.
  • On the other hand, the transferases segment would portray the fastest CAGR of 7.0% during the forecast period.
  • Transferases are extensively used in biotechnology and pharmaceutical research for a wide range of applications.
  • The country has a well-established biotechnology industry and is actively investing in research and development of biocatalyst technologies.

Industrial Enzymes Market Worth $11.05 Billion By 2029 - Market Size, Share, Forecasts, & Trends Analysis Report with COVID-19 Impact by Meticulous Research®

Retrieved on: 
Tuesday, May 10, 2022
International Energy Agency, Pollutant, Detergent, Plant, Animal, Biofuel, Climate, Gasoline, BASF SE, Intake, Transport, Amylase, IFF, Cellulase, Key finding attacks, Carbon, Water, Cellulose, Soap, Dietary supplement, Enzyme, Infection, Energy drink, Industry, Food, Disease, Sugar, Hydrolysis, Awareness, Animal feed, Investment, Population, Cosmetics, DSM (company), Foodservice, Attention, Sale, Fermentation, Biomass, CAGR, International Flavors & Fragrances, Growth, KWV South Africa (Pty) LTD, COVID-19, Greenhouse, BASF, Lipase, Merck Group, Climate change, Temperature, Carbohydrase, International Association, Impact, Health, Drink, Dairy, Wind, Fine chemical, Pharmaceutical industry, Renewable energy, Geography, Textile, Solid

Supply chains were disrupted, resulting in production limitations, complications in raw materials sourcing, and higher delivery costs, impacting the overall industrial enzymes market.

Key Points: 
  • Supply chains were disrupted, resulting in production limitations, complications in raw materials sourcing, and higher delivery costs, impacting the overall industrial enzymes market.
  • Key Findings of the Industrial Enzymes Market Report:
    Based on type, the industrial enzymes market is segmented into carbohydrases, proteases, lipases, and others.
  • Based on application, the industrial enzymes market is segmented into food & beverages, household care, animal feed, biofuel, and other applications.
  • Based on geography, in 2022, North America is expected to account for the largest share of the industrial enzymes market.

Industrial Enzymes Market Worth $11.05 Billion By 2029 - Market Size, Share, Forecasts, & Trends Analysis Report with COVID-19 Impact by Meticulous Research®

Retrieved on: 
Tuesday, May 10, 2022
International Energy Agency, Pollutant, Detergent, Plant, Animal, Biofuel, Climate, Gasoline, BASF SE, Intake, Transport, Amylase, IFF, Cellulase, Key finding attacks, Carbon, Water, Cellulose, Soap, Dietary supplement, Enzyme, Infection, Energy drink, Industry, Food, Disease, Sugar, Hydrolysis, Awareness, Animal feed, Investment, Population, Cosmetics, DSM (company), Foodservice, Attention, Sale, Fermentation, Biomass, CAGR, International Flavors & Fragrances, Growth, KWV South Africa (Pty) LTD, COVID-19, Greenhouse, BASF, Lipase, Merck Group, Climate change, Temperature, Carbohydrase, International Association, Impact, Health, Drink, Dairy, Wind, Fine chemical, Pharmaceutical industry, Renewable energy, Geography, Textile, Solid

Supply chains were disrupted, resulting in production limitations, complications in raw materials sourcing, and higher delivery costs, impacting the overall industrial enzymes market.

Key Points: 
  • Supply chains were disrupted, resulting in production limitations, complications in raw materials sourcing, and higher delivery costs, impacting the overall industrial enzymes market.
  • Key Findings of the Industrial Enzymes Market Report:
    Based on type, the industrial enzymes market is segmented into carbohydrases, proteases, lipases, and others.
  • Based on application, the industrial enzymes market is segmented into food & beverages, household care, animal feed, biofuel, and other applications.
  • Based on geography, in 2022, North America is expected to account for the largest share of the industrial enzymes market.

Global Synthetic Biology Market Trajectory & Analytics Report 2021 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, January 18, 2022
Biotechnology, Science, Health, Other Science, CAGR, Research, Synthetic biology, Oligonucleotide, Incidence, RNA, COVID-19, Enzyme, Growth, Nanotechnology, Biofuel, Government, DNA, Lipase, Intelligence, Awareness, Synthetic, Amylase, Drug development, Technology, Lists of countries and territories, Drug discovery, Investment, Machine learning, Fine chemical, Pet, Pharmaceutical industry

The "Synthetic Biology - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Synthetic Biology - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
  • This segment currently accounts for a 22.9% share of the global Synthetic Biology market.
  • The commanding position of the Oligonucleotides & Synthetic DNA segment is attributed to increasing uptake of synthetic RNA, synthetic DNA and synthetic genes that are used in a broad array of applications.
  • The U.S. Market is Estimated at $3.3 Billion in 2021, While China is Forecast to Reach $2.9 Billion by 2026
    The Synthetic Biology market in the U.S. is estimated at US$3.3 Billion in the year 2021.

Kemin Biofuels Launches ZyloZyme™ AA for Use in Bioethanol Production

Retrieved on: 
Wednesday, July 14, 2021
Chemical substances, Alcohols, Chemistry, Renewable fuels, Ethanol fuel, Ethanol, Biofuel, Amylase, Starch

"We are encouraged by the outcome of this study and the positive results of using ZyloZyme AA in ethanol production," said Brandon Lewis, Ph.D., Senior Technical Services Manager, Kemin Biofuels.

Key Points: 
  • "We are encouraged by the outcome of this study and the positive results of using ZyloZyme AA in ethanol production," said Brandon Lewis, Ph.D., Senior Technical Services Manager, Kemin Biofuels.
  • "Even at low doses, ZyloZyme AA provides robust liquefaction while maintaining ethanol levels and the ethanol-to-solids ratio.
  • ZyloZyme AA is a specialized enzyme allowing ethanol plants to fine tune the amount of amylase used to break down starch, reduce viscosity and improve production output.
  • Kemin is committed to delivering innovation, continuing with the newest enzyme in Kemin Biofuels' portfolio, ZyloZyme AA.